The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results of the OPARATIC trial: A phase I dose escalation study of olaparib in combination with temozolomide (TMZ) in patients with relapsed glioblastoma (GBM).
 
Sarah E. R. Halford
No Relationships to Disclose
 
Garth Cruickshank
No Relationships to Disclose
 
Laurence Dunn
No Relationships to Disclose
 
Sara Erridge
No Relationships to Disclose
 
Lisa Godfrey
No Relationships to Disclose
 
Christopher Herbert
Honoraria - Bristol-Myers Squibb; Merck; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Elekta; Merck; Novartis
 
Sarah Jefferies
Stock and Other Ownership Interests - GlaxoSmithKline (I)
Other Relationship - Roche
 
Juanita Suzanne Lopez
No Relationships to Disclose
 
Catherine McBain
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Bristol-Myers Squibb
 
Marc Pittman
No Relationships to Disclose
 
Rebecca Sleigh
No Relationships to Disclose
 
Colin Watts
No Relationships to Disclose
 
Mark F Webster-Smith
No Relationships to Disclose
 
Anthony J. Chalmers
Honoraria - Astex Pharmaceuticals; AstraZeneca; Bristol-Myers Squibb; Vertex
Research Funding - Astex Pharmaceuticals; AstraZeneca; Vertex